BR9106752A - OLIGONUCLEOTIDEO OR OLIGONUCLEOTIDE ANALOG, PROCESS FOR TREATING AN INFECTION BY CANDIDATE AND PROCESS FOR MODULATING CANDIDATE ACTIVITY - Google Patents

OLIGONUCLEOTIDEO OR OLIGONUCLEOTIDE ANALOG, PROCESS FOR TREATING AN INFECTION BY CANDIDATE AND PROCESS FOR MODULATING CANDIDATE ACTIVITY

Info

Publication number
BR9106752A
BR9106752A BR919106752A BR9106752A BR9106752A BR 9106752 A BR9106752 A BR 9106752A BR 919106752 A BR919106752 A BR 919106752A BR 9106752 A BR9106752 A BR 9106752A BR 9106752 A BR9106752 A BR 9106752A
Authority
BR
Brazil
Prior art keywords
candidate
oligonucleotideo
infection
treating
modulating
Prior art date
Application number
BR919106752A
Other languages
Portuguese (pt)
Inventor
Glenn D Hoke
David J Ecker
Original Assignee
Isis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Pharmaceuticals Inc filed Critical Isis Pharmaceuticals Inc
Publication of BR9106752A publication Critical patent/BR9106752A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates
BR919106752A 1990-08-16 1991-08-15 OLIGONUCLEOTIDEO OR OLIGONUCLEOTIDE ANALOG, PROCESS FOR TREATING AN INFECTION BY CANDIDATE AND PROCESS FOR MODULATING CANDIDATE ACTIVITY BR9106752A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56867290A 1990-08-16 1990-08-16
PCT/US1991/005802 WO1992003455A1 (en) 1990-08-16 1991-08-15 INHIBITION OF $i(CANDIDA)

Publications (1)

Publication Number Publication Date
BR9106752A true BR9106752A (en) 1993-08-17

Family

ID=24272249

Family Applications (1)

Application Number Title Priority Date Filing Date
BR919106752A BR9106752A (en) 1990-08-16 1991-08-15 OLIGONUCLEOTIDEO OR OLIGONUCLEOTIDE ANALOG, PROCESS FOR TREATING AN INFECTION BY CANDIDATE AND PROCESS FOR MODULATING CANDIDATE ACTIVITY

Country Status (6)

Country Link
EP (1) EP0652888A1 (en)
JP (1) JPH0779704B2 (en)
AU (1) AU649734B2 (en)
BR (1) BR9106752A (en)
CA (1) CA2089665A1 (en)
WO (1) WO1992003455A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020055101A1 (en) 1995-09-11 2002-05-09 Michel G. Bergeron Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
DE19654946A1 (en) * 1996-10-22 1998-05-07 Univ Eberhard Karls Detecting fungi resistant to azole antimycotics in clinical samples
DE19643486C1 (en) * 1996-10-22 1998-12-03 Univ Eberhard Karls Detection of resistant fungal cells in clinical material
FR2755145B1 (en) * 1996-10-28 1999-01-15 Gervais Danone Co PROCESS FOR DEMONSTRATING LIVE MICROBIOLOGICAL CONTAMINANTS IN A SAMPLE OF A PRODUCT FOR FOOD USE
US20030049636A1 (en) 1999-05-03 2003-03-13 Bergeron Michel G. Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories
US20100267012A1 (en) 1997-11-04 2010-10-21 Bergeron Michel G Highly conserved genes and their use to generate probes and primers for detection of microorganisms
WO1998057176A1 (en) * 1997-06-10 1998-12-17 Merck & Co., Inc. Protein elongation factor 2 as a target for antifungal and antiparasitic agents
US6096511A (en) * 1997-06-10 2000-08-01 Merck & Co., Inc. Protein elongation factor 2 as a target for antifungal and antiparasitic agents
GB9719044D0 (en) * 1997-09-08 1997-11-12 Inst Of Ophthalmology Assay
CA2388461C (en) 1999-09-28 2013-06-11 Infectio Diagnostic (I.D.I.) Inc. Highly conserved genes and their use to generate probes and primers for the detection of microorganisms
KR100448877B1 (en) * 2002-08-19 2004-09-18 한국전력공사 Apparatus for reducing COD from flue-gas desulfurization waste by electrochemical oxidation process
US20040203006A1 (en) * 2003-04-11 2004-10-14 Cytokinetics, Inc. Novel beta-tubulin protein of Candida glabrata and methods for its use
EP3931325A1 (en) * 2019-02-28 2022-01-05 Universidade do Minho Antisense oligomers for controlling candida albicans infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07501204A (en) * 1991-06-28 1995-02-09 マサチューセッツ インスティテュート オブ テクノロジー Topical oligonucleotide therapy
NZ244820A (en) * 1991-10-25 1994-01-26 Isis Pharmaceuticals Inc Oligonucleotide inhibitor of epstein-barr virus.
GB9125891D0 (en) * 1991-12-05 1992-02-05 Inst Of Cancer The Research Antiviral agent

Also Published As

Publication number Publication date
WO1992003455A1 (en) 1992-03-05
CA2089665A1 (en) 1992-02-17
EP0652888A4 (en) 1993-09-23
AU8635591A (en) 1992-03-17
EP0652888A1 (en) 1995-05-17
JPH06501844A (en) 1994-03-03
AU649734B2 (en) 1994-06-02
JPH0779704B2 (en) 1995-08-30

Similar Documents

Publication Publication Date Title
BR9106752A (en) OLIGONUCLEOTIDEO OR OLIGONUCLEOTIDE ANALOG, PROCESS FOR TREATING AN INFECTION BY CANDIDATE AND PROCESS FOR MODULATING CANDIDATE ACTIVITY
BR9206070A (en) Process for treating fluoroaluminosilicate glass, treated fluoroaluminosilicate glass and ethylenically unsaturated polymeric alkoxysilanes.
BR8805440A (en) PROCESS FOR THE MANUFACTURE OF 1,1,1-TRIFLUORODICLOROEThane AND / OR 1,1,1,2-TETRAFLUOROCLOROEThane BY FLUORATION OF A TETRAHALOETHYLENE
PT93281A (en) A PROCESS AND DEVICE FOR SIMPLIFYING THE USE OF A MULTIPLICITY OF CREDIT CARDS OR SIMILARS
DE69022163T2 (en) STERILE PRODUCT AND METHOD FOR STERILIZING AND ASSEMBLING THIS PRODUCT.
BR9607083A (en) Processes for preparing 1,1-cyclo-propane-dimethanol-1-hydroxy-methyl-cyclo-propane-acetonitrile cyclic sulfide and 1-thio-methyl-propane-acetic acid
BR8804098A (en) COMPOUNDS, COMPOSITIONS AND PROCESS FOR REDUCING THE PHYTOOTOXIDITY OF CULTURE PLANTS
DE69006266T2 (en) Cracking catalyst and process.
BR9609084A (en) A process for treating wood with bacteria
BR9204924A (en) AGRICULTURAL ASSOCIATION, AGRICULTURAL COMPOSITION AND PLANT TREATMENT PROCESS
DE69015040D1 (en) Optical neural network and learning method.
DE69019950D1 (en) CARRIERS FOR CULTIVATING MICROORGANISMS, CARRIERS PRODUCED THEREOF FOR CONTROLLING PARASITAL INFECTION, AND METHOD FOR CONTROLLING PARASITES.
BR9101129A (en) WASTE TREATMENT PROCESS AND OVEN
DE59005066D1 (en) Process and device for sanitizing, disinfecting and / or drying.
BR8703866A (en) PROCESS FOR IMPROVING THE ADHESION OF PAINTS ON Greasy AND / OR HYDROPHOBIZED LEATHERS, APPLICATION OF WATERY DISPERSES, AS WELL AS A BASIS OF ADHERENCE FOR PAINTS OF Greasy AND / or HYDROPHOBIZED LEATHER
DE69012304T2 (en) Eye treatment facility.
PT93510A (en) CONTAINER AND STERILIZATION PROCESS
BR9007874A (en) PROCESS FOR POSTERIOR TREATMENT OF AMPHOTHERAL OR ZWITTERIONIC TENSIVE ASSETS
PT88254A (en) PROCESS FOR THE PREPARATION OF ERITROMYCIN DERIVATIVES A MODIFIED IN C.12
DE69022813T2 (en) Waste treatment.
BR9007285A (en) PROCESS FOR THE BIOLOGICAL TREATMENT OF WATERS SERVED WITH THE AID OF MICROORGANISMS
IT8919735A0 (en) PROCEDURE FOR THE REDUCTION OF CODE FROM INDUSTRIAL OR URBAN WASTEWASTE.
BR9002705A (en) POLYMERIZATION PROCESS, PRODUCT AND COMPOSITION
BR9101496A (en) TISSUE TREATMENT PROCESS
BR8906040A (en) CATALYTIC COMPOSITION, POLYMERIZATION PROCESS AND PRODUCT OBTAINED

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
FC Decision: refusal
B15K Others concerning applications: alteration of classification

Ipc: C12N 15/113 (2010.01), C07K 14/39 (2006.0